Evaluation of Prescription Data for Development of Warfarin Nomogram in Korean Patients with Cerebral Infarction
![]() |
Jang, Ju-Young
(Department of Pharmacy, Kangnam ST, Mary's Hospital, The Catholic University of Korea)
Ko, Kyung-Mi (Department of Pharmacy, Kangnam ST, Mary's Hospital, The Catholic University of Korea) Yoon, Ji-Yeon (Department of Pharmacy, Kangnam ST, Mary's Hospital, The Catholic University of Korea) Han, Ok-Yeon (Department of Pharmacy, Kangnam ST, Mary's Hospital, The Catholic University of Korea) Lim, Sung-Cil (College of Pharmacy, CBITRC, Chungbuk National University) |
1 | American Society of Health-system. AHFS Drug Information, Iron Preparations. 1458 (2008) |
2 | Furie, K. L., Rosenberg, R., Thompson, J. L., Bauer, K., Mohr, J. P., Rosner, B., Sciacca, R., Barzegar, S., Thornell, B., Costigan, T. and Kistler, J. P. : Thrombin generation in noncardioembolic stroke subtypes: the hemostatic system activation study. Neurology 63, 768 (2004) DOI PUBMED ScienceOn |
3 | Kovacs, M. J., Rodger, M., Anderson, D. R., Morrow, B., Kells, G., Kovacs, J., Boyle, E. and Wells, P. S. : Comparison of 10-mg and 5-mg warfarin initiation nomograms together with lowmolecular- weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial. Ann. 138, 714 (2003) |
4 | Yamaguchi, T. : Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese nonvalvular atrial fibrillation-embolism secondary prevention cooperative study group. Stroke 817 (2000) PUBMED |
5 | Roberts, G. W., Herboe, T., Nislsen, C. B. M., et al. : Assessment of an age-adjusted warfarin initiation protocol. Annals of Pharmacotherapy 37, 799 (2003) DOI ScienceOn |
6 | Banet, G. A., Waterman, A. D., Milligan, P. E., Gatchel, S. K. and Gage, B. F. : Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio. Chest. 123, 499 (2003) DOI ScienceOn |
7 | Caldwell, M. D., Berg, R. L., Zhang, K. Q., Glurich, I., Schmelzer, J. R., Yale, S. H., Vidaillet, H. J. and Burmester, J. K. : Evaluation of genetic factors for warfarin dose prediction. Clin. Med. Res. 5, 8 (2007) DOI ScienceOn |
8 | Anderson David R, Wilson S. Jo-Anne, Blundell Jennifer, Petrie David, Leighton Ross, Stanish William, Allexander David, Robinson K. Sue, Burton Erica, Gross Michael. : Comparsion of a nomogramand physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after Arthroplaty. J. Bone Joint Surg Am. 84, 1992 (2002) DOI |
9 | Ng, P. W. : The stroke epidemic. Hong Kong Med. J. 13, 92 (2007) |
10 | Goldstein, J. N., Thomas, S. H., Frontiero, V., Joseph, A., Engel, C., Snider, R., Smith, E. E., Greenberg, S. M. and Rosand, J. : Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke. Jan. 37, 151 (2006) DOI |
11 | Lee, S.-Y., Nam, M.-H., Kim, J. S. and Kim, J.-W. : A case report carrying CYP2C9*3/4 genotype with extremely low warfarin dose resuirement. J. Korean Med. Sci. 22, 557 (2007) DOI ScienceOn |
12 | Nam, J. Y., Choi, K. S., Jeong, Y. M., Namgung, H. W. and Lee, B. K. : Warfarin maintenance dosages in very elderly Korean patients. J. Kor. Soc. Health-Syst. Pharm. 24, 196 (2007) |
13 | Kim, H. J., Pak, H. M., Kim, J. M. and Sohn, K. H. : Evaluation of warfarin initial dosing in korean patients. J. Kor. Soc. Health- Syst. Pharm. 23, 104 (2006) |
14 | Hertzberg, V., Chimowitz, M., Lynn, M., Chester, C., Asbury, W. and Cotsonis, G. : Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study. Clin Trials 5, 23 (2008) DOI ScienceOn |
15 | Zhou, J.-M., Liu, S.-W., Lin, J.-X., Nie, Z.-N., Wu, H.-Y., Zhou, J., Hao, Y., Cai, N.-S. and Ge, J.-B.. : Thromboembolic event rate in patients with persistent or paroxysmal atrial fibrillation post circumferential pulmonary vein isolation: a single center experience in China. China Med. J. 120, 956 (2007) PUBMED |
16 | Garcia, D. A. and Hylek, E. : Reducing the risk for stroke in patients who have atrial fibrillation. Cardiol. Clin. 26, 267 (2008) DOI ScienceOn |
17 | David, A. Garcia MD, Elaine M. Hylek MD, MPH. : Antithrombotic therapy in atrial fibrillation. Clin. Geriar. Med. 22, 155 (2006) DOI ScienceOn |
18 | Wada, Y., Mizushige, K., Ohmori, K., Iwado, Y., Kohno, M. and Matsuo, H. : Prevention of cerebral thromboembolism by lowdose anticoagulant therapy in atrial fibrillation with mitral regurgitation. J. Cardiovasc. Pharmacol. 37, 422 (2001) DOI ScienceOn |
19 | Veenstra, D. L., You, J. H., Rieder, M. J., Farin, F. M., Wilkerson, H. W., Blough, D. K., Cheng, G. and Rettie, A. E. : Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Pharmacogenet Genomics 10, 687 (2005) |
20 | Hankey, G. J. and Warlow, C. P. : Treatment and secondaryprevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 354, 1457 (1999) DOI ScienceOn |
21 | Franke, C. A., Dickerson, L. M. and Carek, P. J. : Improving anticoagulation therapy using point-of-care testing and a standardized protocol. Ann. Fam. Med. 1, 28 (2008) |
22 | Lee, B. K. : Analysis of factors affecting nontherapeutic INRs and determination of practical dosing of warfarin in Korean outpatients with mechanical heart valves. Dept. of Pharmacy graduate school, Chungbuk National University Cheong ju, Korea (2002) |
![]() |